Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep;7(5):229-45.
doi: 10.1177/2040622316658463. Epub 2016 Jul 15.

Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses

Rajesh R Tampi  1 , Deena J Tampi  2 , Silpa Balachandran  3 , Shilpa Srinivasan  4
Affiliations

Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses

Rajesh R Tampi et al. Ther Adv Chronic Dis. 2016 Sep.

Abstract

Background: The purpose of this review is to evaluate the data on the use of antipsychotics in individuals with dementia from meta-analyses.

Methods: We performed a literature search of PubMed, MEDLINE, EMBASE, PsycINFO and Cochrane collaboration databases through 30 November, 2015 using the following keywords: 'antipsychotics', 'dementia' and 'meta-analysis'. The search was not restricted by the age of the patients or the language of the study. However, in the final analysis we only included studies involving patients that were published in English language journals or had official English translations. In addition, we reviewed the bibliographic databases of published articles for additional studies.

Results: This systematic review of the literature identified a total of 16 meta-analyses that evaluated the use of antipsychotics in individuals with dementia. Overall, 12 meta-analyses evaluated the efficacy of antipsychotics among individuals with dementia. Of these, eight also assessed adverse effects. A further two studies evaluated the adverse effects of antipsychotics (i.e. death). A total of two meta-analyses evaluated the discontinuation of antipsychotics in individuals with dementia. Overall, three meta-analyses were conducted in individuals with Alzheimer's disease (AD) whereas one focused on individuals with Lewy Body Dementia (LBD). The rest of the 12 meta-analyses included individuals with dementia.

Conclusions: Antipsychotics have demonstrated modest efficacy in treating psychosis, aggression and agitation in individuals with dementia. Their use in individuals with dementia is often limited by their adverse effect profile. The use of antipsychotics should be reserved for severe symptoms that have failed to respond adequately to nonpharmacological management strategies.

Keywords: antipsychotics; benefits; dementia; meta-analysis; risks; therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest.

Figures

Figure 1.
Figure 1.
PRISMA flow diagram. PRISMA, Preferred Reporting Items for Systematic reviews and Meta-Analyses.
See this image and copyright information in PMC

References

    1. Antonsdottir I., Smith J., Keltz M., Porsteinsson A. (2015) Advancements in the treatment of agitation in Alzheimer’s disease. Expert Opin Pharmacother 16: 1649–1656. - PubMed
    1. Ballard C., Gauthier S., Cummings J., Brodaty H., Grossberg G., Robert P., et al. (2009) Management of agitation and aggression associated with Alzheimer’s disease. Nat Rev Neurol 5: 245–255. - PubMed
    1. Ballard C., Lana M., Theodoulou M., Douglas S., McShane R., Jacoby R., et al. (2008) A randomized, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Med 5: e76 DOI: 10.1371/journal.pmed.0050076. - DOI - PMC - PubMed
    1. Ballard C., Waite J. (2006) The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer’s disease. Cochrane Database Syst Rev 1: CD003476. - PMC - PubMed
    1. Barnes T., Banerjee S., Collins N., Treloar A., McIntyre S., Paton C. (2012) Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services. Br J Psychiatry 201: 221–226. - PubMed

LinkOut - more resources